Table 1 COVID-19 patients’ baseline demographic and clinical characteristics
From: Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients
Demographic parameters | |
Male, n (%) | 21 (70) |
Female, n (%) | 9 (30) |
Age, years | 66.1 ± 15.7 |
Clinical parameters | |
BMI, kg/m2 | 31.1 ± 4.9 |
ARDS, n (%) | 30 (100) |
Maximal CRP, mg/L | 240.2 ± 69.4 |
Duration of ICU stay, days | 12.5 ± 2.7 |
Duration of IMV, days | 10.4 ± 1.9 |
Systemic steroid administration, n (%) | 30 (100) |
Comorbidities | |
Diabetes mellitus, n (%) | 21 (70) |
Coronary heart disease, n (%) | 11 (37) |
Chronic heart failure, n (%) | 9 (30) |
Obesity, n (%) | 24 (80) |
Chronic kidney disease, n (%) | 15 (50) |